These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11980984)

  • 21. Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
    Oliveira ER; Fothergill A; Kirkpatrick WR; Patterson TF; Redding SW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):457-9. PubMed ID: 18329581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in
    Chen M; Cheng T; Xu C; Pan M; Wu J; Wang T; Wu D; Yan G; Wang C; Shao J
    Virulence; 2022 Dec; 13(1):428-443. PubMed ID: 35195502
    [No Abstract]   [Full Text] [Related]  

  • 23. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
    Groll AH; Wood L; Roden M; Mickiene D; Chiou CC; Townley E; Dad L; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2554-63. PubMed ID: 12121932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
    Corvò R; Amichetti M; Ascarelli A; Arcangeli G; Buffoli A; Cellini N; Cionini L; De Renzis C; Emiliani E; Franchini P; Gabriele P; Gobitti C; Grillo Ruggieri F; Bertoni F; Magrini SM; Marmiroli L; Orsatti M; Panizza GM; Tordiglione M; Ziccarelli L; Gava A; Zorat PL; Ghelfi R; Serra GF; Vitale V
    Eur J Cancer Care (Engl); 2008 May; 17(3):270-7. PubMed ID: 18419630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yeast oropharyngeal colonization in human immunodeficiency virus-infected patients in central taiwan.
    Ho MW; Yang YL; Lin CC; Chi CY; Chen HT; Lin PC; Hsieh LY; Chou CH; Chu WL; Wu CP; Lauderdale TL; Lo HJ
    Mycopathologia; 2014 Jun; 177(5-6):309-17. PubMed ID: 24804977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
    Burn AK; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; McCarthy DI; Rinaldi MG; Redding SW
    J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
    Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oropharyngeal candidiasis in the era of antiretroviral therapy.
    Thompson GR; Patel PK; Kirkpatrick WR; Westbrook SD; Berg D; Erlandsen J; Redding SW; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):488-95. PubMed ID: 20156694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
    Kennedy HF; Shankland GS; Bagg J; Chalmers EA; Gibson BE; Williams CL
    Mycoses; 2006 Nov; 49(6):457-62. PubMed ID: 17022761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oropharyngeal Candidiasis in Palliative Care Patients in Denmark.
    Astvad K; Johansen HK; Høiby N; Steptoe P; Ishøy T
    J Palliat Med; 2015 Nov; 18(11):940-4. PubMed ID: 26270132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiology of yeast colonization and oropharyngeal infection other than Candida albicans in patients with HIV infection].
    Masiá Canuto MM; Gutiérrez Rodero F; Ortiz de la Tabla Ducasse V; Martín González C; Escolano Hortelano CM; Mora Rufete A; Martín Hidalgo A
    Med Clin (Barc); 1999 Feb; 112(6):211-4. PubMed ID: 10191483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study.
    Gligorov J; Bastit L; Gervais H; Henni M; Kahila W; Lepille D; Luporsi E; Sasso G; Varette C; Azria D;
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):532-9. PubMed ID: 20594986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
    Wilson AG; Micek ST; Ritchie DJ
    Clin Ther; 2005 Aug; 27(8):1228-37. PubMed ID: 16199247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.